The Genomic Scarring Score as a Biomarker for the Use of PARP Inhibitors in Early-Stage Non-Small Cell Lung Cancer

被引：0
|
作者：
Tsilingiri, K. [1 ]
Chalari, A. [1 ]
Christopoulou, G. [2 ]
Voutsina, A. [3 ]
Vatsellas, I. [1 ]
Loupis, T. [1 ]
Vrachnos, D. [1 ]
Potaris, K. [4 ]
Vamvakaris, I. [5 ]
Zachou, G. [6 ]
Georgoulias, V. [6 ]
Constantoulakis, P. [2 ]
Kotsakis, A. [7 ]
Klinakis, A. [1 ]
机构：
[1] BRFAA, Athens, Greece
[2] Genotypos SA, Athens, Greece
[3] Natl Hellen Res Fdn, Athens, Greece
[4] SOTIRIA Gen Hosp, Dept Thorac Surg, Athens, Greece
[5] SOTIRIA Gen Hosp, Dept Pathol, Athens, Greece
[6] Metropolitan Gen Hosp, Dept Med Oncol, Athens, Greece
[7] Univ Gen Hosp Larisa, Dept Med Oncol, Larisa, Greece
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
non small cell lung cancer; homologous recombination deficiency; PARP inhibition;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.03B.01
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [1] Genomic scarring score predicts the response to PARP inhibitors in non-small cell lung cancer
    Tsilingiri, Katerina
    Chalari, Anna
    Christopoulou, Georgia
    Voutsina, Alexandra
    Constantoulakis, Pantelis
    Potaris, Konstantinos
    Vamvakaris, Ioannis
    Hatzidaki, Dora
    Zachou, Georgina
    Vatsellas, Giannis
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    Klinakis, Apostolos
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [2] Genomic profiling and metastatic risk in early-stage non-small cell lung cancer
    Fick, Cameron N.
    Dunne, Elizabeth G.
    Lankadasari, Manendra B.
    Mastrogiacomo, Brooke
    Asao, Tetsuhiko
    Vanstraelen, Stijn
    Liu, Yuan
    Sanchez-Vega, Francisco
    Jones, David R.
    JTCVS OPEN, 2023, 16 : 9 - 16
  • [3] Genomic scarring score as a criterion for PARP inhibitor administration in early-stage NSCLC
    Klinakis, A.
    Tsilingiri, K.
    Chalari, A.
    Voutsina, A.
    Christopoulou, G.
    Vatselas, G.
    Potaris, K.
    Vamvakaris, I.
    Hatzidaki, D.
    Zachou, G.
    Georgoulias, V.
    Konstantoulakis, P.
    Kotsakis, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S791 - S791
  • [4] Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancer
    Liu, Mengmei
    Yan, Guanghong
    Li, Yanli
    You, Ruiming
    Liu, Lizhu
    Zhang, Dafu
    Yang, Guangjun
    Dong, Xingxiang
    Ding, Yingying
    Yan, Shan
    You, Dingyun
    Li, Zhenhui
    CANCER IMAGING, 2023, 23 (01)
  • [5] Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancer
    Mengmei Liu
    Guanghong Yan
    Yanli Li
    Ruiming You
    Lizhu Liu
    Dafu Zhang
    Guangjun Yang
    Xingxiang Dong
    Yingying Ding
    Shan Yan
    Dingyun You
    Zhenhui Li
    Cancer Imaging, 23
  • [6] Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
    Sonam Puri
    Michael Shafique
    Jhanelle E. Gray
    Current Treatment Options in Oncology, 2018, 19
  • [7] Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
    Puri, Sonam
    Shafique, Michael
    Gray, Jhanelle E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (08)
  • [8] Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer
    Serke, Monika
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 135 - 144
  • [9] Adjuvant chemotherapy for early-stage non-small cell lung cancer
    Visbal, AL
    Leighl, NB
    Feld, R
    Shepherd, FA
    CHEST, 2005, 128 (04) : 2933 - 2943
  • [10] Neoadjuvant chemotherapy in early-stage non-small cell lung cancer
    Salva, Francesc
    Felip, Enriqueta
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 398 - 402
12345